GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

EM People and Markets

Top Section/Ad

Top Section/Ad

Most recent

Korobov to join Deutsche Bank


Third Saudi capital markets banker to leave in recent months
Emerging markets specialist headed to another bank
Departure comes after 19 years at firm
Replacement for Derant Lakoue poached from Standard Bank
More articles/Ad

More articles/Ad

More articles

  • Private sector involvement in suspending debt servicing for the world's poorest countries to alleviate the impact of the coronavirus pandemic progressed this week, with the Institute of International Finance (IIF) publishing guidelines for such an initiative. But countries face a long and tortuous path to reach tangible relief, write Ross Lancaster and Oliver West.
  • The Covid-19 pandemic has caused a “quantum” change in the amount of capital required to finance development, according to the head of the European Bank for Reconstruction and Development (EBRD).
  • Hong Kong’s capital markets were left roiling this week as investors tried to grasp the significance of a new national security law. Some fund managers are jumping on opportunities amid the ensuing confusion, but other market watchers see the city losing its financial edge. Jonathan Breen reports.
  • China’s auto ABS market has seen a slew of tightly priced deals this month, thanks to ample liquidity onshore and the growing strength of domestic investors. While very short-term trades have been popular, appetite is rising for longer revolving structures, said bankers.
  • The China Banking and Insurance Regulatory Commission (CBIRC) has scrapped a number of restrictions hampering the country's insurers from investing in perpetual bonds sold by smaller banks.
  • Equities and investment-grade bonds are overpriced in developed markets, according to Tommy Garvey, member of the asset allocation team at GMO. The US-based investment firm has just slashed its exposure to developed equity markets.